MedPath

MYLERAN

MYLERAN (busulfan) Tablets

Approved
Approval ID

00ca5f69-8944-47f8-8ebf-98b0b8062c20

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 29, 2022

Manufacturers
FDA

Woodward Pharma Services LLC

DUNS: 080406260

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

busulfan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69784-620
Application NumberNDA009386
Product Classification
M
Marketing Category
C73594
G
Generic Name
busulfan
Product Specifications
Route of AdministrationORAL
Effective DateApril 15, 2022
FDA Product Classification

INGREDIENTS (7)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
BUSULFANActive
Quantity: 2 mg in 1 1
Code: G1LN9045DK
Classification: ACTIB
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MYLERAN - FDA Drug Approval Details